Skip to main content
. Author manuscript; available in PMC: 2012 Oct 15.
Published in final edited form as: Eur J Pharmacol. 2011 Mar 31;668(3):435–442. doi: 10.1016/j.ejphar.2011.02.045

FIG. 9. DD-NAc-PGP inhibits [125I]-CXCL8 binding.

FIG. 9

Indicated concentrations of DD-NAc-PGP were either pre-incubated at 4°C for 30 min prior to radioligand addition, or added simultaneously with 7.8ng/ml [125I]-CXCL8. Cells were then kept at 4°C for 90 min to allow binding to occur and resulting cell associated radiation was measured using a Packerd Gamma Counter. (* P value<0.05)